Phase

phase 2 (8,812)

n/a (7,263)

phase 1 (5,695)

phase 1/phase 2 (3,198)

phase 3 (2,439)

phase 4 (1,241)

early phase 1 (752)

phase 2/phase 3 (539)

Funder Type

Other (29,040)

Industry (4,238)

NIH (3,607)

U.S. Fed (168)

Study Type

Interventional (29,940)

Observational (6,499)

Observational [Patient Registry] (521)

Expanded Access (93)

Glioma stem-like cells

Showing 1 - 25 of >10,000

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Glioblastoma, Glioblastoma Multiforme, Glioma Trial in Los Angeles (Dendritic cell vaccination, in addition to standard

Completed

Glioblastoma
+4 more

Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy
Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab

Los Angeles, California

Cedars-Sinai Medical Center

Nov 18, 2021

Glioblastoma, Glioma, Malignant Trial in Rome (Biological sample collection)

Recruiting

Glioblastoma
Glioma, Malignant

Biological sample collection

Rome, Italy

Fondazione Policlinico Universitario A. Gemelli IRCCS

Mar 6, 2023

Glioblastoma, Glioma, Malignant Trial in Rome (Biological sample collection, Dissecting ciliogenesis players, Validating

Recruiting

Glioblastoma
Glioma, Malignant

Biological sample collection
+2 more

Rome, Italy

Fondazione Policlinico Universitario A. Gemelli IRCCS

Mar 6, 2023

Mapping of Tumor Stem Cells in Resection Marigin During

Recruiting

Glioma, Malignant

GlioStem

Stockholm, Sweden

Karolinska University Hospital

Sep 22, 2022

Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

Not yet recruiting

Acute Myeloid Leukemia
+5 more

Cytokine Induced Memory-like Natural Killer Cells
Interleukin-2

Boston, Massachusetts
+1 more

Nov 14, 2023

Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an

Completed

Has Results

Glioma
+7 more

Neural stem cells loaded with an oncolytic adenovirus

Duarte, California
+1 more

Dec 28, 2022

Recurrent Glioblastoma Trial in Los Angeles (Activated T cells)

Not yet recruiting

Recurrent Glioblastoma

Activated T cells

Los Angeles, California

Cedars-Sinai Medical Center

Apr 21, 2022

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Withdrawn

Recurrent Anaplastic Astrocytoma
+7 more

Neural Stem Cells-expressing CRAd-S-pk7
Resection

(no location specified)

Nov 22, 2022

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Active, not recruiting

Recurrent Anaplastic Astrocytoma
+6 more

Carboxylesterase-expressing Allogeneic Neural Stem Cells
+4 more

Duarte, California

City of Hope Medical Center

Jun 7, 2022

Malignant Glioma, High Grade Glioma Trial in Birmingham, Washington, Gainesville (TTRNA-DC vaccines with GM-CSF,

Recruiting

Malignant Glioma
High Grade Glioma

TTRNA-DC vaccines with GM-CSF
+4 more

Birmingham, Alabama
+2 more

Feb 2, 2023

Diffuse Intrinsic Pontine Glioma (DIPG), Brain Stem Glioma Trial in Gainesville (TTRNA-DC vaccines with GM-CSF, TTRNA-xALT,

Recruiting

Diffuse Intrinsic Pontine Glioma (DIPG)
Brain Stem Glioma

TTRNA-DC vaccines with GM-CSF
+5 more

Gainesville, Florida

UF Health Shands Children's Hospital

Apr 29, 2022

Primary Ovarian Insufficiency Trial in Zhengzhou (Cell therapy)

Active, not recruiting

Primary Ovarian Insufficiency

Cell therapy

Zhengzhou, Henan, China

The First Affiliated Hospital of Zhengzhou University

Aug 4, 2021

Charcot Marie Tooth Disease, Type 1 Trial in Seoul (CLZ-2002)

Recruiting

Charcot Marie Tooth Disease, Type 1

CLZ-2002

Seoul, Gangnam-gu, Korea, Republic of

Samsung Medical center

Jul 18, 2023

Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)

Completed

Has Results

Glioblastoma
Gliosarcoma

3-Dimensional Conformal Radiation Therapy
+10 more

Seattle, Washington

Fred Hutch/University of Washington Cancer Consortium

Mar 4, 2022

Ovarian Cancer Trial in Oklahoma City (Unesbulin)

Active, not recruiting

Ovarian Cancer

Unesbulin

Oklahoma City, Oklahoma

University of Oklahoma Health Sciences Center

Feb 21, 2022

Stem Cell Transplant Complications, Knee Osteoarthritis Trial in Guangzhou (very small embryonic-like stem cell)

Withdrawn

Stem Cell Transplant Complications
Knee Osteoarthritis

very small embryonic-like stem cell

Guangzhou, Guangdong, China

Biological treatment center in Fuda cancer hospital

Oct 13, 2020

Stem Cell Transplant Complications, Skin Inflammation Trial in Guangzhou (Very small embryonic-like stem cell)

Withdrawn

Stem Cell Transplant Complications
Skin Inflammation

Very small embryonic-like stem cell

Guangzhou, Guangdong, China

Biological treatment center in Fuda cancer hospital

Oct 13, 2020

Stem Cell Transplant Complications, Premature Ovarian Failure Trial in Guangzhou (very small embryonic-like stem cell)

Withdrawn

Stem Cell Transplant Complications
Premature Ovarian Failure

very small embryonic-like stem cell

Guangzhou, Guangdong, China

Biological treatment center in Fuda cancer hospital

Oct 13, 2020

Organic Erectile Dysfunction Trial in Guangzhou (Very small embryonic-like stem cell(VSEL))

Withdrawn

Organic Erectile Dysfunction

Very small embryonic-like stem cell(VSEL)

Guangzhou, Guangdong, China

Central laboratory in Fuda cancer hospital

Oct 13, 2020

Malignant Glioma, Tumors Trial in Philadelphia (IGF-1R/AS ODN; Surgery with tissue harvest and implantation 20 diffusion

Completed

Malignant Glioma
Neoplasms

IGF-1R/AS ODN; Surgery with tissue harvest and implantation 20 diffusion chambers in the rectus sheath with IGF-1R/AS ODN within 24 hours of craniotomy, implanted for 48 hours.